Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook

CNBC • U.S. • 33 minutes ago

Merck narrowed its 2026 sales guidance and hiked its adjusted profit outlook.

Read from Source (Read More) ← Back to Homepage # U.S.

Transgender Idaho Residents Sue After State Criminalizes Use of Bathrooms

The lawsuit seeks to block a state bathroom law that is the nation’s most restrictive, with penalties that could includ…

Lilly hiked its full-year sales outlook by $2 billion, and also raised its adjusted profit guidance.

Eli Lilly is slated to report first-quarter earnings before the bell on Thursday, in one of the most closely watched re…

The defense secretary said at a House hearing that President Barack Obama had fired 197 generals, a figure that the Pen…

During his first public appearance on Capitol Hill since the war began, the defense secretary lashed out at lawmakers i…

Sen. Jeff Merkley, D-Ore., led a letter — first reported by CNBC — to the CFTC asking for stricter rules for companies …